Great Edit. Now Prove It! — Why Sanger Sequencing And TIDE GxP Have Their Place In Approved Gene And Cell Therapies.
Cell 2026 · 12 November 2026 · 10:10–10:20 · Conference Room 7
Great Edit. Now Prove It! — Why Sanger Sequencing And TIDE GxP Have Their Place In Approved Gene And Cell Therapies. was a session at Cell 2026 on 12 November 2026 in London, with 1 speaker on record.
Speakers
- Jelle ten Hoeve — Speaker Chief Executive Officer, Tide Genetics